Resources

Explore our online resource catalog to discover publications, presentations, tools, and related resources for global health practitioners, decision-makers, advocates, and more.

All resources

Read our latest

2395 Result s
2395 Result s
    Date
    From
    To
  1. This poster demonstrates the predictive validity of an assay developed by Arbor Vita and PATH. For this study, cervical swab specimens collected from women screened, diagnosed, and managed in rural settings in China were tested for the presence of HPV-16 DNA then examined for HPV16-E6 expression. Results confirmed E6 is a potential diagnostic marker. Presented at: 23rd Papillomavirus Conference and Clinical Workshop, September 1, 2006; Prague, Czech Republic.
    Published: September 2006
    Resource Page
  2. This poster outlines the evaluation of two immunochromatographic strip test platforms for the best limit of detection: one uses an antibody colloidal gold conjugate which is visually interpreted yielding qualitative results, and the other uses an antibody paramagnetic particle conjugate which is read by an instrument yielding quantitative results. The resulting limits of detection of these two methods are compared to the target limit of detection for an E6 assay of ~50 pg. Presented at: 23rd Papillomavirus Conference and Clinical Workshop, September 1, 2006; Prague, Czech Republic.
    Published: September 2006
    Resource Page
  3. Published: September 2006
    Resource Page
    Part of a Series
  4. This issue of Directions in Global Health features five PATH projects: our collaboration with the World Health Organization on the Meningitis Vaccine Project; prevention of mother-to-child HIV transmission in Ukraine; a small grants program that is catalyzing behavior change in Africa; the Inter-Act project, which is training truck drivers to slow the HIV epidemic in India; and an evaluation of neonatal resuscitators.
    Published: August 2006
    Resource Page
    Part of a Series
  5. Scientists have been working for decades to develop a preventive malaria vaccine. While they have successfully demonstrated that such a vaccine is possible, many challenges continue to impede progress on the road to an effective malaria vaccine. As a result, the Malaria Vaccine Advisory Committee to the World Health Organization (WHO), coordinated by the WHO Initiative for Vaccine Research, called for a collective effort to explore and address the challenges. This effort resulted in the Malaria Vaccine Technology Roadmap process.
    Published: August 2006
    Resource Page